<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04726085</url>
  </required_header>
  <id_info>
    <org_study_id>RP-20-028</org_study_id>
    <nct_id>NCT04726085</nct_id>
  </id_info>
  <brief_title>Ibuprofen Versus Indomethacin Following Emergent Cerclage Placement</brief_title>
  <acronym>TOCO</acronym>
  <official_title>Efficacy of Ibuprofen Versus Indomethacin as Perioperative Prophylactic Treatment Following Emergent Cerclage Placement for Pregnancy Prolongation: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Woman's</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Woman's</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cervical insufficiency is defined as painless cervical dilation in the second trimester.&#xD;
      Cervical insufficiency can ultimately lead to second trimester loss of pregnancy. Cerclages&#xD;
      are utilized in pregnancies affected by cervical insufficiency in order to prolong&#xD;
      gestational latency. There have been several studies investigating the efficacy of&#xD;
      perioperative medications for cerclage placement and the effects they have on gestational&#xD;
      latency. Some such studies have found that perioperative indomethacin in combination with&#xD;
      antibiotics have significantly increased gestational latency when compared to placebo.&#xD;
      Indomethacin has traditionally been the tocolytic of choice with cerclage placement. At our&#xD;
      hospital, ibuprofen has been the tocolytic of choice for cerclage placement secondary to&#xD;
      pharmacy availability. Our study aims to evaluate whether gestational latency differs among&#xD;
      patients undergoing emergent cerclage whether they receive perioperative ibuprofen or&#xD;
      indomethacin.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gestational latency</measure>
    <time_frame>From cerclage placement to delivery</time_frame>
    <description>Days from cerclage placement to delivery, assessed up to 26 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preterm birth</measure>
    <time_frame>At delivery</time_frame>
    <description>Birth before 37 weeks gestation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Preterm Labor</condition>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen 600 mg q6 hours for 24 hours- total dose of 2400mg- after emergent cerclage placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Indomethacin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Indomethacin 50 mg q8 hours for 24 hours- total dose of 150mg- after emergent cerclage placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indomethacin 150mg</intervention_name>
    <description>Patients will be randomized to either received perioperative indomethacin or ibuprofen at the time of their emergent cerclage placement for 24 hours following surgery. Patient will be followed up through our electronic medical record system to determine gestational latency to evaluate if ibuprofen is inferior to indomethacin.</description>
    <arm_group_label>Indomethacin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 2400mg</intervention_name>
    <description>Patients will be randomized to either received perioperative indomethacin or ibuprofen at the time of their emergent cerclage placement for 24 hours following surgery. Patient will be followed up through our electronic medical record system to determine gestational latency to evaluate if ibuprofen is inferior to indomethacin.</description>
    <arm_group_label>Ibuprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Viable, singleton pregnancy&#xD;
&#xD;
          -  â‰¥ 18 years old&#xD;
&#xD;
          -  Gestational age 16 weeks 0/7 days - 23 week 6/7 days (inclusive)&#xD;
&#xD;
          -  Intact membranes at time of enrollment&#xD;
&#xD;
          -  Planning to deliver at Woman's Hospital&#xD;
&#xD;
          -  Exam or ultrasound indicated cerclage placement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to treatments (i.e. ibuprofen or indomethacin)&#xD;
&#xD;
          -  Unwilling to be randomized to treatment&#xD;
&#xD;
          -  Prophylactic cerclage placement&#xD;
&#xD;
          -  Temperature greater than 100.4&#xD;
&#xD;
          -  Known major fetal congenital anomaly&#xD;
&#xD;
          -  Prior cerclage placement during the current pregnancy&#xD;
&#xD;
          -  Recent (within 7 days) receipt of ibuprofen or indomethacin&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela Simmons, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Woman's Hospital, Louisiana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pamela Simmons, DO</last_name>
    <phone>225-924-8464</phone>
    <email>pamela.simmons@womans.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ericka Seidemann</last_name>
    <phone>225-231-5296</phone>
    <email>ericka.Seidemann@womans.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Woman's Hospital</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Simmons, DO</last_name>
      <phone>225-924-8464</phone>
      <email>pamela.simmons@womans.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cerclage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Indomethacin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

